4-ALKOXYPYRIDAZINE DERIVATIVES AS FAST DISSOCIATING DOPAMINE 2 RECEPTOR ANTAGONISTS
申请人:MacDonald Gregor James
公开号:US20100063058A1
公开(公告)日:2010-03-11
The present invention relates to (1-benzyl-piperidin-4-yl)-(4-alkoxy-pyridazin-3-y1)-amines that are fast dissociating dopamine 2 receptor antagonists, processes for preparing these compounds, pharmaceutical compositions comprising these compounds as an active ingredient. The compounds find utility as medicines for treating or preventing central nervous system disorders, for example schizophrenia, by exerting an antipsychotic effect without motor side effects.
4-alkoxypyridazine derivatives as fast dissociating dopamine 2 receptor antagonists
申请人:MacDonald Gregor James
公开号:US08906921B2
公开(公告)日:2014-12-09
The present invention relates to (1-benzyl-piperidin-4-yl)-(4-alkoxy-pyridazin-3-y1)-amines that are fast dissociating dopamine 2 receptor antagonists, processes for preparing these compounds, pharmaceutical compositions comprising these compounds as an active ingredient. The compounds find utility as medicines for treating or preventing central nervous system disorders, for example schizophrenia, by exerting an antipsychotic effect without motor side effects.
[EN] 4-ALKOXYPYRIDAZINE DERIVATIVES AS FAST DISSOCIATING DOPAMINE 2 RECEPTOR ANTAGONISTS<br/>[FR] DÉRIVÉS DE 4-ALKOXYPYRIDAZINE EN TANT QU'ANTAGONISTES DU RÉCEPTEUR 2 DE LA DOPAMINE À DISSOCIATION RAPIDE
申请人:JANSSEN PHARMACEUTICA NV
公开号:WO2008128995A1
公开(公告)日:2008-10-30
[EN] The present invention relates to (1-benzyl-piperidin-4-yl) - (4-alkoxy-pyridazin-3-yl) - amines of formula (I) that are fast dissociating dopamine 2 receptor antagonists, processes for preparing these compounds, pharmaceutical compositions comprising these compounds as an active ingredient. The compounds find utility as medicines for treating or preventing central nervous system disorders, for example schizophrenia, by exerting an antipsychotic effect without motor side effects. [FR] L'invention concerne des (1-benzyl-pipéridine-4-yl)-(4-alkoxy-pyridazine-3-yl)- amines représentés par la formule (I) qui sont des antagonistes du récepteur 2 de la dopamine à dissociation rapide, des procédés d'obtention de ces composés et des compositions pharmaceutiques contenant lesdits composés en tant que principe actif. Ces composés conviennent pour le traitement ou la prévention des troubles du système nerveux central, notamment de la schizophrénie, grâce à leur action antipsychotique sans effets moteurs secondaires.